title: Pharmacological modulation of anti-tumor immunity induced by oncolytic viruses.
abstract: Oncolytic viruses (OVs) not only kill cancer cells by direct lysis but also generate a significant anti-tumor immune response that allows for prolonged cancer control and in some cases cures. How to best stimulate this effect is a subject of intense investigation in the OV field. While pharmacological manipulation of the cellular innate anti-viral immune response has been shown by several groups to improve viral oncolysis and spread, it is increasingly clear that pharmacological agents can also impact the anti-tumor immune response generated by OVs and related tumor vaccination strategies. This review covers recent progress in using pharmacological agents to improve the activity of OVs and their ability to generate robust anti-tumor immune responses.
authors.affiliation: Center for Innovative Cancer Research, Ottawa Hospital Research Institute , Ottawa, ON , Canada ; Faculty of Medicine, University of Ottawa , Ottawa, ON , Canada.
authors.forename: Nicole E
authors.initials: NE
authors.lastname: Forbes
authors.affiliation: Center for Innovative Cancer Research, Ottawa Hospital Research Institute , Ottawa, ON , Canada ; Faculty of Medicine, University of Ottawa , Ottawa, ON , Canada.
authors.forename: Ramya
authors.initials: R
authors.lastname: Krishnan
authors.affiliation: Center for Innovative Cancer Research, Ottawa Hospital Research Institute , Ottawa, ON , Canada ; Faculty of Medicine, University of Ottawa , Ottawa, ON , Canada.
authors.forename: Jean-Simon
authors.initials: JS
authors.lastname: Diallo
keywords: Oncolytic virotherapy; anti-tumor immunity; cancer; chemotherapy; combination therapy; immuno-modulatory therapy; pharmacological therapy
references.citation: Mol Ther. 2008 Jun;16(6):1041-7
references.pmid: 18388912
references.citation: Cancer Gene Ther. 2007 Aug;14(8):756-61
references.pmid: 17557108
references.citation: Clin Cancer Res. 2009 Mar 1;15(5):1730-40
references.pmid: 19223497
references.citation: Nat Rev Clin Oncol. 2009 Nov;6(11):638-47
references.pmid: 19786984
references.citation: J Virol. 2009 Mar;83(5):2130-9
references.pmid: 19073718
references.citation: J Natl Cancer Inst. 2006 Mar 1;98(5):298-300
references.pmid: 16507823
references.citation: Oncol Rep. 2014 Apr;31(4):1581-8
references.pmid: 24535016
references.citation: Nat Biotechnol. 2012 Jul 10;30(7):658-70
references.pmid: 22781695
references.citation: J Clin Invest. 2010 May;120(5):1551-60
references.pmid: 20364090
references.citation: Semin Oncol. 2001 Dec;28(6):626-33
references.pmid: 11740821
references.citation: Nat Rev Genet. 2009 May;10(5):295-304
references.pmid: 19308066
references.citation: Br J Cancer. 2008 Nov 18;99(10):1613-22
references.pmid: 18941459
references.citation: Trends Genet. 2011 Nov;27(11):465-74
references.pmid: 21885149
references.citation: Cell Death Dis. 2013 Jul 18;4:e728
references.pmid: 23868061
references.citation: Cancer Lett. 2010 Aug 28;294(2):178-86
references.pmid: 20163915
references.citation: Int J Cancer. 2013 Apr 1;132(7):1592-601
references.pmid: 22949155
references.citation: Arch Neurol. 2006 Nov;63(11):1572-8
references.pmid: 17101825
references.citation: PLoS Pathog. 2014 Jan;10(1):e1003836
references.pmid: 24453963
references.citation: Mol Ther. 2012 Apr;20(4):759-68
references.pmid: 22233582
references.citation: Mol Ther. 2010 Feb;18(2):251-63
references.pmid: 20029399
references.citation: Cell. 2011 Mar 4;144(5):646-74
references.pmid: 21376230
references.citation: Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):14981-6
references.pmid: 18815361
references.citation: Eur J Cancer. 2009 Jul;45(10):1764-72
references.pmid: 19251409
references.citation: Nat Med. 1999 Aug;5(8):881-7
references.pmid: 10426310
references.citation: J Virol. 2011 Sep;85(18):9346-58
references.pmid: 21734048
references.citation: N Engl J Med. 2010 Sep 16;363(12):1117-27
references.pmid: 20843246
references.citation: J Clin Oncol. 2009 Dec 1;27(34):5763-71
references.pmid: 19884534
references.citation: Invest New Drugs. 2013 Jun;31(3):696-706
references.pmid: 22886613
references.citation: Leukemia. 2007 Apr;21(4):838-42
references.pmid: 17268529
references.citation: Mol Ther. 2013 Sep;21(9):1749-57
references.pmid: 23732991
references.citation: Clin Cancer Res. 2008 Jan 1;14(1):259-69
references.pmid: 18172278
references.citation: Nature. 2011 Aug 31;477(7362):99-102
references.pmid: 21886163
references.citation: Nat Med. 2013 Mar;19(3):329-36
references.pmid: 23396206
references.citation: Mol Ther. 2008 Sep;16(9):1637-42
references.pmid: 18628758
references.citation: J Virol. 2013 Jan;87(1):659-65
references.pmid: 23115279
references.citation: Clin Cancer Res. 2008 Nov 15;14(22):7358-66
references.pmid: 19010851
references.citation: J Biol Chem. 2007 Jan 19;282(3):1757-68
references.pmid: 17114181
references.citation: Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9578-83
references.pmid: 15210966
references.citation: J Biol Chem. 1994 Feb 18;269(7):5241-8
references.pmid: 8106507
references.citation: Int J Cancer. 2011 Sep 1;129(5):1265-76
references.pmid: 21710499
references.citation: Hum Gene Ther. 2005 Dec;16(12):1473-83
references.pmid: 16390278
references.citation: Acta Biochim Pol. 1998;45(1):1-11
references.pmid: 9701490
references.citation: J Immunol. 2001 Mar 1;166(5):3130-42
references.pmid: 11207265
references.citation: Hum Gene Ther. 2010 Oct;21(10):1311-25
references.pmid: 20497039
references.citation: Cancer Immunol Immunother. 2009 Oct;58(10):1627-34
references.pmid: 19221744
references.citation: Nat Rev Immunol. 2009 Mar;9(3):162-74
references.pmid: 19197294
references.citation: Nat Rev Immunol. 2006 Nov;6(11):836-48
references.pmid: 17063185
references.citation: J Virol. 2014 May;88(10):5263-76
references.pmid: 24574398
references.citation: Front Genet. 2013 Sep 20;4:184
references.pmid: 24062768
references.citation: J Immunol. 1986 Apr 15;136(8):2747-54
references.pmid: 2937837
references.citation: Front Oncol. 2013 May 08;3:108
references.pmid: 23658859
references.citation: Clin Cancer Res. 2009 Jan 15;15(2):511-9
references.pmid: 19147756
references.citation: Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1576-81
references.pmid: 20080710
references.citation: Clin Cancer Res. 2011 Feb 1;17(3):581-8
references.pmid: 21106728
references.citation: Mol Ther. 2007 Nov;15(11):1991-7
references.pmid: 17712331
references.citation: PLoS One. 2012;7(10):e46617
references.pmid: 23056370
references.citation: PLoS One. 2013;8(3):e59082
references.pmid: 23527092
references.citation: Cancer Gene Ther. 2012 Aug;19(8):588-91
references.pmid: 22677940
references.citation: Cancer Immunol Res. 2013 Nov;1(5):309-19
references.pmid: 24777969
references.citation: J Natl Cancer Inst. 2012 Jan 4;104(1):42-55
references.pmid: 22173583
references.citation: Br J Cancer. 2014 Jan 7;110(1):83-93
references.pmid: 24281006
references.citation: Cancer Cell. 2003 Oct;4(4):263-75
references.pmid: 14585354
references.citation: J Virol. 2012 Apr;86(8):4566-77
references.pmid: 22318143
references.citation: Mol Ther. 2013 Jun;21(6):1212-23
references.pmid: 23546299
references.citation: J Biol Chem. 2011 Jul 29;286(30):26319-26
references.pmid: 21636578
references.citation: Sci Transl Med. 2014 Mar 5;6(226):226ra32
references.pmid: 24598590
references.citation: Cancer Gene Ther. 2011 Oct;18(10):734-43
references.pmid: 21836633
references.citation: J Virol. 2013 Sep;87(18):10283-94
references.pmid: 23864625
references.citation: Neuro Oncol. 2013 Jul;15(7):904-20
references.pmid: 23585629
references.citation: Mol Ther. 2010 Jun;18(6):1123-9
references.pmid: 20389287
references.citation: Exp Hematol. 2013 Dec;41(12):1038-49
references.pmid: 24067362
references.citation: Onco Targets Ther. 2013 Aug 20;6:1119-27
references.pmid: 23986643
references.citation: J Interferon Cytokine Res. 2007 Dec;27(12):1013-7
references.pmid: 18184042
references.citation: Mol Ther. 2011 Sep;19(9):1737-46
references.pmid: 21673660
references.citation: Mol Ther. 2011 Apr;19(4):797-804
references.pmid: 21245852
references.citation: Clin Cancer Res. 2011 Jun 1;17(11):3686-96
references.pmid: 21505062
references.citation: Int J Cancer. 2014 Sep 1;135(5):1238-46
references.pmid: 24474587
references.citation: Handb Clin Neurol. 2014;122:503-11
references.pmid: 24507533
references.citation: Lancet Oncol. 2008 Jun;9(6):533-42
references.pmid: 18495536
references.citation: Cancer Chemother Pharmacol. 2008 Apr;61(5):875-82
references.pmid: 17726607
references.citation: Nat Rev Drug Discov. 2012 Feb 01;11(2):103-4
references.pmid: 22293561
references.citation: Mol Cancer Ther. 2009 Jan;8(1):141-51
references.pmid: 19139123
references.citation: Cancer Res. 2005 Aug 1;65(15):6850-7
references.pmid: 16061668
references.citation: J Immunol. 1997 Mar 1;158(5):2390-7
references.pmid: 9036989
references.citation: Curr Opin Genet Dev. 2010 Feb;20(1):87-90
references.pmid: 20006486
references.citation: Cancer Gene Ther. 2013 Oct;20(10):582-9
references.pmid: 24030211
references.citation: J Hepatol. 2006 May;44(5):869-78
references.pmid: 16545484
references.citation: J Clin Oncol. 2000 Jan;18(1):158-66
references.pmid: 10623706
references.citation: Gynecol Oncol. 2013 Sep;130(3):518-24
references.pmid: 23756180
references.citation: Clin Cancer Res. 2009 Apr 15;15(8):2777-88
references.pmid: 19351762
references.citation: Int J Cancer. 2013 Sep 15;133(6):1479-88
references.pmid: 23444104
references.citation: Stem Cells Transl Med. 2013 Sep;2(9):655-66
references.pmid: 23926209
references.citation: J Immunol. 2012 Sep 15;189(6):3209-20
references.pmid: 22896634
references.citation: Mol Ther. 2013 Apr;21(4):887-94
references.pmid: 23295947
references.citation: Nat Prod Rep. 2012 Apr;29(4):457-75
references.pmid: 22270059
references.citation: Int J Cancer. 2012 Jul 1;131(1):253-63
references.pmid: 21834073
references.citation: Clin Cancer Res. 2013 Nov 1;19(21):5952-9
references.pmid: 24056786
references.citation: Nat Rev Drug Discov. 2011 Feb;10(2):127-40
references.pmid: 21283107
references.citation: Gene Ther. 2004 Jan;11(2):214-23
references.pmid: 14712306
references.citation: J Virol. 2000 May;74(10):4765-75
references.pmid: 10775615
references.citation: Gut. 2010 Oct;59(10):1416-26
references.pmid: 20675696
references.citation: Gene Ther. 2010 Dec;17(12):1506-16
references.pmid: 20686506
references.citation: Cancer Res. 2013 Feb 15;73(4):1265-75
references.pmid: 23393196
references.citation: Clin Cancer Res. 2009 Jan 15;15(2):561-9
references.pmid: 19147761
references.citation: Clin Exp Pharmacol Physiol. 2012 Mar;39(3):311-20
references.pmid: 21834865
references.citation: Mol Cancer Ther. 2009 Apr;8(4):980-7
references.pmid: 19372571
references.citation: Mol Ther. 2007 Sep;15(9):1686-93
references.pmid: 17579581
references.citation: Mol Ther. 2008 Oct;16(10):1665-73
references.pmid: 18665155
references.citation: Mol Cancer. 2011 Feb 21;10:20
references.pmid: 21338484
references.citation: Clin Cancer Res. 2002 Aug;8(8):2666-74
references.pmid: 12171899
references.citation: Immunology. 2008 Jun;124(2):234-46
references.pmid: 18217957
references.citation: Ann Oncol. 2006 May;17 Suppl 5:v7-12
references.pmid: 16807468
references.citation: J Neuroimmunol. 2005 Nov;168(1-2):128-37
references.pmid: 16171875
references.citation: Cancer Gene Ther. 2009 Mar;16(3):237-45
references.pmid: 18949013
references.citation: Gene Ther. 2013 Mar;20(3):255-61
references.pmid: 22476202
references.citation: Nat Med. 2013 Apr;19(4):458-64
references.pmid: 23455712
references.citation: Int J Cancer. 2011 Sep 15;129(6):1503-10
references.pmid: 21128236
references.citation: Chin Med J (Engl). 2011 Apr;124(7):1082-7
references.pmid: 21542972
references.citation: PLoS One. 2010 Dec 30;5(12):e14462
references.pmid: 21283510
references.citation: Gene Ther. 2011 Dec;18(12):1157-65
references.pmid: 21975464
references.citation: J Interferon Cytokine Res. 2002 Apr;22(4):457-62
references.pmid: 12034028
references.citation: Mol Cancer. 2009 Jul 14;8:47
references.pmid: 19594950
references.citation: Proc Natl Acad Sci U S A. 2006 Aug 22;103(34):12873-8
references.pmid: 16908838
references.citation: Mol Ther. 2008 May;16(5):879-85
references.pmid: 18388918
references.citation: Mol Ther. 2012 Oct;20(10):1998-2003
references.pmid: 22871663
references.citation: Blood. 2010 Apr 15;115(15):3109-17
references.pmid: 20130243
references.citation: J Natl Cancer Inst. 2006 Jan 4;98(1):38-50
references.pmid: 16391370
references.citation: PLoS One. 2013 Sep 02;8(9):e73650
references.pmid: 24023896
references.citation: Mol Ther. 2008 Sep;16(9):1546-55
references.pmid: 18648350
references.citation: Anticancer Res. 2011 Dec;31(12):4569-74
references.pmid: 22199332
references.citation: Mol Ther. 2013 Nov;21(11):2043-53
references.pmid: 23985699
references.citation: N Engl J Med. 2005 Mar 10;352(10):987-96
references.pmid: 15758009
references.citation: J Exp Med. 2012 Apr 9;209(4):661-9
references.pmid: 22412156
references.citation: Cancer Res. 2005 Dec 15;65(24):11510-9
references.pmid: 16357160
references.citation: Clin Cancer Res. 2010 Jan 15;16(2):541-53
references.pmid: 20068104
references.citation: J Virol. 2007 Feb;81(3):1251-60
references.pmid: 17108021